Brown-Forman
BF-ANYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $31.74 Prior regular-session close from the quote source.
- $30.57–$31.27 Regular-session low and high so far today.
- 143.6K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $23.01–$32.32 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own BF-A if management sustains pricing/mix, executes cost savings, and avoids repeated brand impairments.
BF-A price history
Loading recent earnings…
Investment thesis
What must happen next
Brown-Forman's premium brand portfolio and pricing/mix ability will sustain high gross margins (protecting per-unit economics) even if volumes are pressured.StrengtheningMateriality: High
Gross profit of $2,378,000,000 in FY2026 despite a modest revenue decline — implying high gross margin (~60% of revenue). If true, the company retains pricing power that preserves profitability and cash generation; if false, margin erosion will force trade-offs between marketing spend and returns or trigger impairments.
Watch: A sustained consumer shift toward lower-priced spirits or aggressive premium campaigns by global competitors (e.g., Diageo/Pernod) that erode premium pricing.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Gross profit of $2,378,000,000 in FY2026 despite a modest revenue decline — implying high gross margin (~60% of revenue).
Open source ↗The restructuring initiative and working-capital actions will sustainably increase operating cash flow conversion, providing cash for reinvestment and shareholder returns.StrengtheningMateriality: High
Operating cash flow rose to $1,000,000,000 in FY2026 from $598,000,000 in FY2025 and $647,000,000 in FY2024. Sustained higher cash conversion funds buybacks/dividends or brand investment without requiring dilutive transactions; if it reverses, reinvestment/shareholder returns will be constrained.
Watch: Rising commodity, packaging, or logistics costs that offset restructuring savings.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating cash flow rose to $1,000,000,000 in FY2026 from $598,000,000 in FY2025 and $647,000,000 in FY2024.
Open source ↗Revenue recovery will depend on expanding premiumization and execution in international channels; without mix/price gains or restored growth in key markets, top-line will remain flat or decline.HoldingMateriality: Medium
Company operates on six continents and positions itself in the premium-plus category (Item 1), providing channels for international premiumization. Top-line traction is the engine for long-term EPS growth; if premium mix and geographic expansion fail, earnings growth must come only from cost cuts or M&A.
Watch: Currency headwinds (MD&A explicitly adjusts organic measures for forex) that depress reported sales even if local demand holds.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Company operates on six continents and positions itself in the premium-plus category (Item 1), providing channels for international premiumization.
Open source ↗Recurring brand impairments would indicate weaker long-term brand economics and presage lower pricing power and margins.HoldingMateriality: Medium
MD&A documents non-cash impairment charges in fiscal 2025 and fiscal 2026 (Gin Mare and Diplomático) and these items impact operating results and net income. If impairments recur, management may need to write down goodwill/intangibles and future margins/returns will be structurally lower; if impairments stop, intangible asset values and future earnings are more secure.
Watch: Management successfully integrates acquisitions and delivers market-share gains for acquired brands, avoiding future impairments.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
MD&A documents non-cash impairment charges in fiscal 2025 and fiscal 2026 (Gin Mare and Diplomático) and these items impact operating.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Brown-Forman's premium brand portfolio and pricing/mix ability will sustain high gross margins (protecting per-unit economics) even if volumes are pressured. If true, the company retains pricing power that preserves profitability and cash generation; if false, margin erosion will force trade-offs between marketing spend and returns or trigger impairments.
The restructuring initiative and working-capital actions will sustainably increase operating cash flow conversion, providing cash for reinvestment and shareholder returns. Sustained higher cash conversion funds buybacks/dividends or brand investment without requiring dilutive transactions; if it reverses, reinvestment/shareholder returns will be constrained.
Revenue recovery will depend on expanding premiumization and execution in international channels; without mix/price gains or restored growth in key markets, top-line will remain flat or decline. Top-line traction is the engine for long-term EPS growth; if premium mix and geographic expansion fail, earnings growth must come only from cost cuts or M&A.
Recurring brand impairments would indicate weaker long-term brand economics and presage lower pricing power and margins. If impairments recur, management may need to write down goodwill/intangibles and future margins/returns will be structurally lower; if impairments stop, intangible asset values and future earnings are more secure.
All standing thesis claims
Original report summary
management sustains pricing/mix, executes cost savings, and avoids repeated brand impairments.
Bull case and bear case
Bull case and bear case for Brown Forman
Where the evidence on Brown Forman stands: Holding on the latest evidence (Nov 9, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.
Bull case: what the evidence supports
Brown-Forman's premium brand portfolio and pricing/mix ability will sustain high gross margins (protecting per-unit economics) even if volumes are pressured.
The restructuring initiative and working-capital actions will sustainably increase operating cash flow conversion, providing cash for reinvestment and shareholder returns.
Revenue recovery will depend on expanding premiumization and execution in international channels; without mix/price gains or restored growth in key markets, top-line will remain flat or decline.
Recurring brand impairments would indicate weaker long-term brand economics and presage lower pricing power and margins.
Bear case: what would count against it
A sustained consumer shift toward lower-priced spirits or aggressive premium campaigns by global competitors (e.g., Diageo/Pernod) that erode premium pricing.
Rising commodity, packaging, or logistics costs that offset restructuring savings.
Currency headwinds (MD&A explicitly adjusts organic measures for forex) that depress reported sales even if local demand holds.
Thesis-Break Engine
Thesis-break watch · Brown Forman
Loading the break-condition record for Brown Forman.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedEntered a material definitive agreement.
Brown Forman filed an SEC 8-K on 2026-09-21: Entered a material definitive agreement. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Brown Forman filed an SEC 8-K on 2026-09-02: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedRegulation FD disclosure.
Brown Forman filed an SEC 8-K on 2026-07-23: Regulation FD disclosure. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- A sustained consumer shift toward lower-priced spirits or aggressive premium campaigns by global competitors (e.g., Diageo/Pernod) that erode premium pricing.
- Rising commodity, packaging, or logistics costs that offset restructuring savings.
- Currency headwinds (MD&A explicitly adjusts organic measures for forex) that depress reported sales even if local demand holds.
- Management successfully integrates acquisitions and delivers market-share gains for acquired brands, avoiding future impairments.
BF-A news
Loading headlines…
Financial statements
BF-A income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
BF-A: quick answers
- What is BF-A's short interest?
- As of October 30, 2026, 598,494 BF-A shares were sold short, down 6.0% from the count before. At the stock's average daily volume that is 5.0 days to cover. FINRA publishes the count twice a month. BF-A short interest history
- Which well-known investors own BF-A?
- 1 of the 37 well-known funds tracked here reported BF-A shares in their latest 13F filing. By share of the fund's portfolio: Markel Group (Tom Gayner), 0.2%. Fund portfolios
BF-A in well-known investors’ portfolios
1 of 37 funds reported BF-A shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Tom GaynerMarkel Group | 0.18% | $22.6M | No change | Q3 2026 |
